TY - JOUR
T1 - The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes
AU - Song, Jianxun
AU - Salek-Ardakani, Shahram
AU - So, Takanori
AU - Croft, Michael
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/1
Y1 - 2007/1
N2 - CD28-deficient T cells arrest at the G1-S transition of the cell cycle. Here we show that this is controlled by the kinase aurora B, which exists in a complex with survivin and mammalian target of rapamycin (mTOR). Expression of aurora B in Cd28-/- T cells augmented phosphorylation of mTOR substrates, expression of cyclin A, hyperphosphorylation of retinoblastoma protein and activation of cyclin-dependent kinases 1 and 2 and promoted cell cycle progression. Interleukin 2 enhanced aurora B activity, and inactive aurora B prevented interleukin 2-induced proliferation. Moreover, expression of aurora B restored Cd28-/- T cell proliferation and promoted inflammation in vivo. These data identify aurora B, along with survivin and mTOR, as a regulator of the G1-S checkpoint in T cells.
AB - CD28-deficient T cells arrest at the G1-S transition of the cell cycle. Here we show that this is controlled by the kinase aurora B, which exists in a complex with survivin and mammalian target of rapamycin (mTOR). Expression of aurora B in Cd28-/- T cells augmented phosphorylation of mTOR substrates, expression of cyclin A, hyperphosphorylation of retinoblastoma protein and activation of cyclin-dependent kinases 1 and 2 and promoted cell cycle progression. Interleukin 2 enhanced aurora B activity, and inactive aurora B prevented interleukin 2-induced proliferation. Moreover, expression of aurora B restored Cd28-/- T cell proliferation and promoted inflammation in vivo. These data identify aurora B, along with survivin and mTOR, as a regulator of the G1-S checkpoint in T cells.
UR - http://www.scopus.com/inward/record.url?scp=33847001284&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847001284&partnerID=8YFLogxK
U2 - 10.1038/ni1413
DO - 10.1038/ni1413
M3 - Article
C2 - 17128276
AN - SCOPUS:33847001284
SN - 1529-2908
VL - 8
SP - 64
EP - 73
JO - Nature Immunology
JF - Nature Immunology
IS - 1
ER -